Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Enterprise Value: 2020-2022

Historic Enterprise Value for Atea Pharmaceuticals (AVIR) over the last 3 years, with Dec 2022 value amounting to $400.6 million.

  • Atea Pharmaceuticals' Enterprise Value rose 1968.83% to $400.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $400.6 million, marking a year-over-year increase of 115.95%. This contributed to the annual value of $283.0 million for FY2024, which is 11.19% up from last year.
  • Atea Pharmaceuticals' Enterprise Value amounted to $400.6 million in Q4 2022, which was up 309.49% from -$191.2 million recorded in Q3 2022.
  • In the past 5 years, Atea Pharmaceuticals' Enterprise Value registered a high of $4.3 billion during Q1 2021, and its lowest value of -$217.7 million during Q1 2022.
  • For the 3-year period, Atea Pharmaceuticals' Enterprise Value averaged around $631.7 million, with its median value being -$19.3 million (2020).
  • Per our database at Business Quant, Atea Pharmaceuticals' Enterprise Value skyrocketed by 25,032.96% in 2021 and then plummeted by 283.20% in 2022.
  • Over the past 3 years, Atea Pharmaceuticals' Enterprise Value (Quarterly) stood at $2.6 billion in 2020, then crashed by 100.82% to -$21.4 million in 2021, then spiked by 1,968.83% to $400.6 million in 2022.
  • Its Enterprise Value was $400.6 million in Q4 2022, compared to -$191.2 million in Q3 2022 and -$93.4 million in Q2 2022.